Delivery Order SPE2DB24D1205-SPE2DB25FCZUW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a contract ceiling value of $10,059.24. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was made without set-aside restrictions, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a contract value of $4,747.76 and an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials valued at $40,827.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting an open competition award. The order is scheduled for completion by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $2,702.00 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. This competitively awarded, non-set-aside contract has a ceiling value of $2,111.38 and a delivery deadline of August 4, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. The contract utilizes firm fixed pricing...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 ml vials of the pharmaceutical drug ferumoxytol, valued at $6,484.80. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,012.72 contract is for the supply of 510 mg/17 ml vials of the iron supplement Ferumoxytol, with a period of performance through April 2025. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- The Defense Logistics Agency (DLA) awarded a $2,553.24 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply the medication Ferumoxytol 510 mg/17 ml vial. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZUWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center for federal pharmaceutical procurement operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to military healthcare systems and other government agencies. Ferumoxytol, an iron replacement therapy product, represents one component of the company's extensive portfolio of pharmaceutical products delivered through this strategic contract vehicle to support military and veteran healthcare needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/22/25 |